ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough leukemia: antibody drug tafasitamab enters trial
Disease control Recruiting nowThis study tests a drug called tafasitamab in children aged 3 to 17 with B-cell leukemia that has come back or not responded to treatment. The drug is an antibody that helps the immune system find and kill leukemia cells. The trial has two parts: first, finding the best dose, and…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cell therapy offers hope for tough blood cancers
Disease control Recruiting nowThis study tests a new treatment called CTD402 for people with T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (T-LBL) that has come back or not responded to other treatments. Participants receive one infusion of CTD402 and are monitored for safety and how w…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: BIOHENG THERAPEUTICS US LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC